Viona Pharmaceuticals recalls Dapsone Gel 7.5% (90g) due to crystallization risk. This Rx-only medication, manufactured by Zydus Lifesciences, may cause issues if stored improperly.
Crystallization
Viona Pharmaceuticals is recalling Dapsone Gel 7.5% (90g) because of a crystallization risk. This prescription-only medication could potentially cause problems if stored incorrectly.
Crystallization in the gel could lead to changes in the medication's consistency or effectiveness. This might affect how the drug works or causes issues if the product is not stored properly.
Prescription patients using Dapsone Gel 7.5% (90g) from Viona Pharmaceuticals. Those with the specific lot numbers T400514 or T400808 are most at risk.
Check for the product name 'Dapsone Gel 7.5% (90g)' with lot numbers T400514 (expiring 02/2026) or T400808 (expiring 03/2026).
Look for the lot numbers T400514 or T400808 on the packaging.
The recall does not specify if the product is safe to use; it mentions crystallization risk but does not detail the consequences.
The recall record does not provide a remedy, so no specific action is required beyond checking the product details.
Check for the lot numbers T400514 (expiring 02/2026) or T400808 (expiring 03/2026) on the packaging.
We’ve drafted a message you can send Viona to request your refund or repair — edit it as you like.
Subject: Recall D-0172-2025 — Viona Viona Hello, I own a Viona that is covered by recall D-0172-2025 from Viona. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
